CareDx to Participate in Upcoming Investor Conferences
BRISBANE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Maag, Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in two upcoming investor conferences.
30th Annual Piper Jaffray Healthcare Conference in New York City
-- Peter Maag will present on Wednesday, November 28th at 1:00 PM ET
Evercore ISI HealthCONx Conference in Boston
-- Peter Maag will present on Thursday, November 29th at 8:45 AM ET
Live audio webcasts of the 30th Annual Piper Jaffray Healthcare Conference and Evercore ISI HealthCONx Conference presentations will be available online from the investor relations section of the CareDx website at http://investors.caredx.com. The webcast replay of the presentations will be available approximately one hour following the conclusion of the live presentation and will be available on the Company’s website for 90 days.
About CareDx CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products along the pre- and post-transplant testing continuum.
For more information, please visit: www.CareDx.com.
CONTACTS:Investor RelationsDavid ClairIntegrated Corporate Relations, Inc.email@example.com